Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 12, 2022
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders
Johanna Nilsson, Julius Constantinescu, Bengt Nellgård, et al.
Neurology
|
February 20, 2026
Reader Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test
Andrei Bieger, Wagner S Brum, Wyllians Vendramini Borelli, et al.
Nature Reviews. Neurology
|
May 18, 2022
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
Thomas K Karikari, Nicholas J Ashton, Gunnar Brinkmalm, et al.
Cannabis and Cannabinoid Research
|
November 17, 2022
Endocannabinoid System Biomarkers in Alzheimer's Disease
Pâmela C L Ferreira, Bruna Bellaver, Guilherme Povala, et al.
Molecular Neurodegeneration
|
February 16, 2024
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
Juan Lantero-Rodriguez, Gemma Salvadó, Anniina Snellman, et al.
Cell & Bioscience
|
December 13, 2021
Soluble amyloid-beta isoforms predict downstream Alzheimer's disease pathology
Guilherme Povala, Bruna Bellaver, Marco Antônio De Bastiani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 27, 2023
Levels of Alzheimer's disease blood biomarkers are altered after food intake-A pilot intervention study in healthy adults
Hanna Huber, Nicholas J Ashton, Alina Schieren, et al.
Alzheimer'S Research & Therapy
|
December 21, 2022
CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
Joel Simrén, Wagner S Brum, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 28, 2025
Exploring inflammation-related protein expression and its relationship with TSPO PET in Alzheimer's disease
Ilaria Pola, Nicholas J Ashton, Marco Antônio De Bastiani, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
March 21, 2022
A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease
Wagner S Brum, Marco Antônio de Bastiani, Andrei Bieger, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Movement Disorders : Official Journal of the Movement Disorder Society
|
December 12, 2022
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders
Johanna Nilsson, Julius Constantinescu, Bengt Nellgård, et al.
Neurology
|
February 20, 2026
Reader Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test
Andrei Bieger, Wagner S Brum, Wyllians Vendramini Borelli, et al.
Nature Reviews. Neurology
|
May 18, 2022
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
Thomas K Karikari, Nicholas J Ashton, Gunnar Brinkmalm, et al.
Cannabis and Cannabinoid Research
|
November 17, 2022
Endocannabinoid System Biomarkers in Alzheimer's Disease
Pâmela C L Ferreira, Bruna Bellaver, Guilherme Povala, et al.
Molecular Neurodegeneration
|
February 16, 2024
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
Juan Lantero-Rodriguez, Gemma Salvadó, Anniina Snellman, et al.
Cell & Bioscience
|
December 13, 2021
Soluble amyloid-beta isoforms predict downstream Alzheimer's disease pathology
Guilherme Povala, Bruna Bellaver, Marco Antônio De Bastiani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 27, 2023
Levels of Alzheimer's disease blood biomarkers are altered after food intake-A pilot intervention study in healthy adults
Hanna Huber, Nicholas J Ashton, Alina Schieren, et al.
Alzheimer'S Research & Therapy
|
December 21, 2022
CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals
Joel Simrén, Wagner S Brum, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 28, 2025
Exploring inflammation-related protein expression and its relationship with TSPO PET in Alzheimer's disease
Ilaria Pola, Nicholas J Ashton, Marco Antônio De Bastiani, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
March 21, 2022
A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease
Wagner S Brum, Marco Antônio de Bastiani, Andrei Bieger, et al.
Page
of 6